Market-traded companies, such as Abbott Laboratories (NYSE:ABT), Danaher Corporation (NYSE:DNR), and Thermo Fisher Scientific (TMO), may have an important role to play in helping the U.S. to survive the COVID-19 (aka coronavirus) crisis.
Emergency Use Authorization (EUA) allows USFDA to facilitate the use of medical countermeasures, such as COVID-19 testing, during public health emergencies. USFDA has already granted EUAs to ABT, DNR, TMO, and the other market-traded companies identified later in this article, which may serve to expedite the rollout of new COVID-19 testing methodologies via their existing platforms,